Table 3

EBV status and demographic characteristics and clinical presentations in NHL cases
EBV-DNA positive EBV-DNA negative p-value
Age
1-4 years 2 (40%) 3 (60%) 0.813
5-9 years 17 (70.8%) 7 (29.2%)
10-14 years 2 (33.3%) 4 (66.7%)
Sex
Male 10 (71.4%) 4 (28.6%) 0.22
Female 11 (52.4%) 10 (47.6%)
NHL subtype
BL 19 (59.4%) 13 (40.6%) 0.652
Non-BL 2 (66.7%) 1 (33.3%)
Primary anatomical site
Jaw 7 (43.8%) 9 (56.2%) 0.247
Abdomen 12 (75%) 4 (25%)
Lymph nodes 2 (66.7%) 1 (33.3%)
Clinical stage
Early 10 (52.6%) 9 (47.4%) 0.332
Late 11 (68.6%) 5 (31.4%)

Kabyemera et al.

Kabyemera et al. BMC Pediatrics 2013 13:4   doi:10.1186/1471-2431-13-4

Open Data